⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Alger Russell Innovation Index Updates for Second Quarter 2026
prnewswire.com
ADBE
DOX
GNTX
KVYO
MRK
RBLX
TRMB
Z
ZS
CORT
DV
GTM
ILMN
NTAP
OKTA
P
QCOM
TDC
TWLO
ZM
In Vitro Toxicity Testing Market to Reach $28.0 Billion by 2030, Driven by Rising R&D Costs and Regulatory Push for Animal Testing Alternatives
globenewswire.com
TMO
MRK
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
businesswire.com
MRK
Abu Dhabi annonce un partenariat avec MSD pour renforcer l'excellence opérationnelle et élargir l'accès aux soins dans toute la région
prnewswire.com
MRK
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
prnewswire.com
MRK
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
prnewswire.com
MRK
The Jane Coffin Childs Fund for Medical Research Names its 2026 Fellows
prnewswire.com
JNJ
MRK
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
globenewswire.com
MRK
PFE
GSK
GILD
The Quest to Repair What Multiple Sclerosis Takes Away
globenewswire.com
QNTM
NVS
MRK
TGTX
BMY
MilliporeSigma Announces Hiba Therapeutics as Winner of 2026 North American Advance Biotech Grant
globenewswire.com
MRK